Stock listing

NASDAQ:BDSI BioDelivery Sciences International Inc Stock

Follow BioDelivery Sciences International Inc into a list and get an email when it puts out news.

Last close · NASDAQ:BDSI

$5.59 USD

Close on Mar 22, 2022 · No longer trades

Jul 25, 2002 to last close +69.4% · monthly closes, Jul 25, 2002 – Mar 22, 2022
Lowest – highest close
$0.78 – $18.15 USDSince Jul 25, 2002 · lowest Dec 28, 2011 · highest Sep 12, 2014

Delisted NASDAQ:BDSI no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:BDSI
Asset type
Stock
Exchange
NASDAQ
Currency
USD

BioDelivery Sciences International Inc on 6ix

Calls
4 calls with a replay · 4 with a transcript · latest Nov 3, 2021
Decks
1 deck · latest Apr 3, 2009

Events

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (April 2009)Investor deck36 slidesApr 3, 2009

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Mary Theresa Coelho
Other companies: Hookipa Pharma Inc (EVP and CFO, Director · Since at least Apr 3, 2023); Inotiv, Inc. (Director · Oct 16, 2023 – Apr 1, 2025 · Past); Gamida Cell Ltd (Chief Financial Officer · May 22, 2023 – Jun 12, 2023 · Past); CinCor Pharma Inc (EVP CFO & Chief BD Officer · Jan 6, 2022 – Jan 11, 2022 · Past); GridAI Technologies Corp. (Director · Aug 11, 2021 – Jan 2, 2024 · Past); Balchem Corporation (Chief Financial Officer · Oct 23, 2017 – Oct 26, 2018 · Past)
See Remarks · Jan 15, 2019 – Jan 29, 2021 · Past
Peter Greenleaf
Other companies: Pelthos Therapeutics Inc. (Director · Since at least Jul 1, 2025); Aurinia Pharmaceuticals Inc (Chief Executive Officer, Director · Since at least Jan 1, 2021); Antares Pharma Inc (Director · Dec 12, 2018 – May 24, 2022 · Past); Kiora Pharmaceuticals, Inc. (Director · Jul 10, 2018 – Feb 1, 2019 · Past); Avalo Therapeutics, Inc. (Director · Mar 27, 2018 – Aug 7, 2019 · Past); Sucampo Pharmaceuticals Inc (Chief Executive Officer · Sep 30, 2017 – Feb 13, 2018 · Past)
Director · May 21, 2018 – Mar 22, 2022 · Past
Jeffrey Bailey
Other companies: Aurinia Pharmaceuticals Inc (Board Director · Since at least Aug 18, 2023); Rein Therapeutics, Inc. (Director · Mar 15, 2018 – Jun 17, 2022 · Past); Lantheus Holdings, Inc. (CEO and President, Director · Jun 24, 2015 – Aug 31, 2015 · Past); Landauer Inc (Director · Apr 17, 2015 – Oct 19, 2017 · Past); King Pharmaceuticals Inc (Chief Commercial Officer · Aug 30, 2010 – Mar 1, 2011 · Past)
Chief Executive Officer, Director · Mar 9, 2020 – Mar 22, 2022 · Past
Todd Davis
Other companies: Palvella Therapeutics, Inc. (Director · Since at least Dec 13, 2024); Pelthos Therapeutics Inc. (Director · Since at least Feb 15, 2024); Ligand Pharmaceuticals Incorporated (Chief Executive Officer · Since at least May 25, 2010); Vaxart, Inc. (Director · Oct 25, 2019 – Aug 4, 2022 · Past)
Director · May 21, 2018 – Mar 22, 2022 · Past
W. Mark Watson
Other companies: Vaxart, Inc. (Lead Independent Director · Since at least Aug 4, 2022); Sykes Enterprises Incorporated (Director · May 22, 2018 – Aug 27, 2021 · Past); Inhibitor Therapeutics Inc. (Director · Aug 14, 2015 – Dec 22, 2020 · Past)
Director · Dec 8, 2016 – Mar 22, 2022 · Past
Charles Bramlage
Other companies: Eiger Biopharmaceuticals Inc (Director · Mar 22, 2016 – Apr 12, 2017 · Past); Valeant Pharmaceuticals International Inc (President, Europe · Oct 30, 2007 – Oct 30, 2007 · Past)
Director · Jul 17, 2014 – Aug 14, 2017 · Past
Timothy Tyson
Other companies: Syros Pharmaceuticals, Inc. (Director · Sep 16, 2022 – Jun 5, 2024 · Past); Tyme Technologies Inc (Director · Jul 27, 2017 – Sep 16, 2022 · Past)
Director · Oct 4, 2016 – Aug 14, 2017 · Past
Francis E Odonnell Jr
Other companies: Inhibitor Therapeutics Inc. (Chief Executive Officer, Director · Since at least Jun 6, 2016)
Director · Jun 15, 2016 – May 11, 2020 · Past
John Golubieski
Other companies: Axsome Therapeutics, Inc. (Chief Financial Officer · Aug 4, 2017 – Aug 4, 2017 · Past)
See Remarks · Oct 25, 2021 – Mar 22, 2022 · Past
Scott M. Plesha
Other companies: Pelthos Therapeutics Inc. (CEO and President, Director · Since at least Jul 2, 2025)
See Remarks · Jan 27, 2021 – Mar 22, 2022 · Past
All 12 people
PersonSeat
Benny WardEVP of Busi. & Strategic Dev. · Sep 7, 2010 – Mar 16, 2012 · Past
Thomas D'AlonzoDirector · Apr 23, 2013 – Aug 14, 2017 · Past

Open People

Log in to ask 6ix AI your own questions about BioDelivery Sciences International Inc.